Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer
Conditions: Triple-negative Breast Cancer Interventions: Drug: Quercetin; Drug: Dasatinib; Drug: Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as a Chemotherapy-sparing Regimen for Stage II TNBC (Triple Negative Breast Cancer) Patients
Conditions: Triple Negative Breast Cancer Interventions: Drug: Pembrolizumab; Drug: INBRX-106 Sponsors: Providence Health& Services; Inhibrx, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Prospective Cohort Study of Immunotherapy Resistance in Metastatic Colorectal Cancer Patients With MSI
Conditions: Colorectal Cancer Metastatic; Microsatellite Instability-High Colorectal Cancer Sponsors: Federation Francophone de Cancerologie Digestive Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
MEDECA - Markers in Early Detection of Cancer
Conditions: Cancer; Diagnosis Interventions: Diagnostic Test: Blood sampling Sponsors: Danderyd Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.
Conditions: De-escalated Radiotherapy; Head and Neck Cancer Interventions: Radiation: Continuous, hyperfractionated, accelerated radiotherapy(CHART) Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
IV Dexmedetomidine vs Oral Gabapentin and Their Combination for Postoperative Analgesia in Cancer Patients Undergoing Modified Radical Mastectomy
Conditions: Breast Cancer; Pain, Postoperative; Pain, Acute Interventions: Drug: Dexmedetomidine Hydrochloride 0.5 MG/ML; Drug: Gabapentin Sponsors: National Cancer Institute, Egypt Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
Conditions: Esophageal Carcinoma Interventions: Drug: Serplulimab Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)
Conditions: Cancer Pain; Oncology Pain Interventions: Other: Reiki Sponsors: Case Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW
Conditions: Non-small Cell Lung Cancer Interventions: Drug: sunvozertinib in combination with Anlotinib Sponsors: Hunan Province Tumor Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer
Conditions: Triple-negative Breast Cancer Interventions: Drug: Inosine; Drug: Taxane/Anthracycline/Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1/platinum Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX
Conditions: Locally Advanced Pancreatic Cancer; Metastatic Pancreatic Cancer Interventions: Drug: Neulapeg; Other: Control Sponsors: Yonsei University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.
Conditions: Oral Mucositis (Ulcerative) Due to Radiation Interventions: Drug: N-Acetyl-Cysteine with Institutional standard care; Drug: Institutional standard care Sponsors: Mansoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment
Conditions: Endometrial Cancer Interventions: Procedure: All women older than 18 newly diagnosed with endometrial cancer of all stages and histotypes Sponsors: University Hospital, Gasthuisberg; Fondazione Policlinico Universitario Agostino Gemelli IRCCS; University Medical Centre Maribor Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011
Conditions: Advanced Breast Cancer Interventions: Drug: SYHX2011 Sponsors: CSPC Ouyi Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1
Conditions: Prostate Cancer Interventions: Diagnostic Test: PET-CT imaging subsystem of the RefleXion X1 System Device Sponsors: University of Texas Southwestern Medical Center; RefleXion Medical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
